glp 1 inhibitor drugs Glucagon-like peptide-1 GLP-1 receptor agonists or DPP-4

Researchers are examining whether drugs currently approved to treat obesity and type 2 diabetes could be useful for a wider range of health challenges.

Is allulose a natural alternative to GLP-1 drugs for fat loss

Oral GLP-1 RA are also under development and early data shows similar WL efficacy to semaglutide 2.4mg

In addition, this report is a consensus of expert endocrinologists representing South Asian countries including India, Pakistan, Bangladesh, Nepal, Sri Lanka, Afghanistan and the Maldives on essential recommendations related to the use of GLP-1 RAs in a real-world scenario.

Gastrointestinal (GI) adverse eventsparticularly nausea, vomiting, diarrhea, and constipationare the most common side effects, generally emerging during dose escalation and resolving over time